SCOTTSDALE, Ariz.--(BUSINESS WIRE)--NJOY, America’s number one electronic cigarette company, today announced the results of a pilot study that has been accepted for publication in the American Journal of Health Behavior and will be published online on October 1, 2013. The study, supported by NJOY and led by independent researchers Mitchell Nides, Ph.D. and Scott Leischow, Ph.D. evaluated nicotine delivery from the NJOY® Kings Bold Electronic Delivery System (ENDS) and its short-term potential for smoking reduction or cessation. Results indicated that the NJOY Kings Bold ENDS delivered nicotine at a rate comparable to some FDA-approved nicotine replacement therapy products and that use of the product during the course of the one-week study led to short-term smoking reduction.
The open-label study, consisting of twenty-five smokers ages 18 to 65 who were not interested in quitting, found:
- Mean daily cigarette smoking decreased from the baseline week to the trial week in 89% of subjects, with a statistically significant mean reduction in cigarettes smoked per day of 39%.
- Smoking was reduced by 50% or more in 32% of subjects.
- 16% of subjects had reduced their consumption of cigarettes to 0 by the end of the study period.
- Subjects had generally favorable perceptions of the NJOY Kings product at the end of the one-week trial period, with more than half reporting “high satisfaction” with a number of product features.
The results suggest that the NJOY Kings product delivered enough nicotine to suppress craving and was generally liked. However, the small number of subjects and short one-week testing period limit the study’s generalizability. Thus, while the results indicated that the NJOY Kings product has potential for use in smoking reduction and cessation, larger trials are needed.
“NJOY is actively engaged in expanding the science base on the health effects of electronic cigarettes and their potential to reduce the harms associated with traditional tobacco cigarettes,” said Dr. Richard Carmona, former Surgeon General of the United States and the Chair of NJOY’s Scientific Advisory Committee. “These preliminary findings underscore the need for further research on the category and its potential for harm reduction.”
About the Researchers:
Mitchell Nides, Ph.D., is the Director and co-developer of Picture Quitting, the Entertainment Industry’s Quit Smoking Program. From 1987 to 1999, Dr. Nides was a smoking cessation researcher and counselor in the Pulmonary and Critical Care Department of the UCLA School of Medicine. In 1993, he founded Los Angeles Clinical Trials, where he has served as the Principal Investigator of dozens of clinical trials testing the safety and efficacy of smoking cessation products, including nicotine and non-nicotine smoking cessation drugs.
Scott J. Leischow, Ph.D., is a Senior Associate Consultant with the Department of Research and the Co-lead for Cancer Prevention and Control at the Mayo Clinic. Dr. Leischow served as a senior adviser for tobacco policy at the U.S. Department of Health and Human Services, served as president of the Society for Research on Nicotine and Tobacco, was a professor and the associate director at the College of Medicine and Public Health at the University of Arizona, worked in biobehavioral and social sciences research at the Arizona Cancer Center, and served as Chief of the Tobacco Control Research Branch at the National Cancer Institute.
About the American Journal of Health Behavior:
The American Journal of Health Behavior seeks to improve the quality of life through multidisciplinary health efforts in fostering a better understanding of the multidimensional nature of both individuals and social systems as they relate to health behaviors. The journal is in its 37th year of publication; moreover, abstracts and full text of all journal articles, from 1999 onwards, are available online to view and download. Abstracts may be freely accessed by everyone. Articles are available for download by users and institutions with a current subscription or can be purchased individually. To access a copy of the manuscript on October 1, 2013 CLICK HERE or you may contact the publisher for a pre-publication copy at http://www.ajhb.org/index.htm.
About NJOY:
NJOY is the most popular electronic cigarette brand in America and is known as the industry's "Gold Standard" due to its best-in-class products, patent-pending technology, superior branding, experienced management team and most responsible business practices. The first independent electronic cigarette company to support the nationally recognized We Card Program and join its Manufacturers Advisory Council, NJOY is available in more than 70,000 retail stores nationwide including 24 of the nation's top 25 convenience store chains. NJOY offers a variety of rechargeable and non-rechargeable electronic cigarette products made for adult smokers. These products provide nicotine and rich tobacco and menthol flavor without tobacco smoke or odor. NJOY is a trademarked electronic cigarette brand and is headquartered in Scottsdale, Arizona. To learn more about NJOY products visit www.NJOY.com.
